Hypoxia-induced collagen synthesis of human lung fibroblasts by activating the angiotensin system

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 24029-24045

  Liu, Shan Shan ^a   Wang, Hao Yan ^a   Tang, Jun Ming ^b   Zhou, Xiu Mei ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin ii; Collagen synthesis; Hypoxic hlf 1; Nuclear factor appab

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4, 5, 6, 7 TETRAHYDRO 1H IMIDAZO [4, 5 C] PYRIDINE 6 CARBOXYLIC ACID; ALPHA TUBULIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE; RAS PROTEIN; TELMISARTAN; UNCLASSIFIED DRUG;

ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; LUNG FIBROBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANGIOTENSINOGEN; BENZIMIDAZOLES; BENZOATES; CELL HYPOXIA; CELL LINE; COLLAGEN TYPE I; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; LUNG; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; PYRIDINES; PYRROLIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; THIOCARBAMATES;

EID: 84890186958     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141224029     Document Type: Article

References (43)

1. Robinson, C.M.; Neary, R.; Levendale, A.; Watson, CJ.; Baugh, J.A., Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Respir. Res. 2012, 13, 74.
2. Tzouvelekis, A.; Harokopos, V.; Paparountas, T.; Oikonomou, N.; Chatziioannou, A.; Vilaras, G.; Tsiambas, E.; Karameris, A.; Bouros, D.; Aidinis, V., Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis. Am. J. Respir. Crit. Care Med. 2007, 176, 1108-1119.
3. Tuder, R.M.; Yun, J.H, Bhunia, A.; Fijalkowska, I., Hypoxia and chronic lung disease. J. Mol. Med. 2007, 85, 1317-1324.
4. Urquhart, D.S.; Montgomery, H.; Jaffé, A., Assessment of hypoxia in children with cystic fibrosis. Arch. Dis. Child. 2005, 90, 1138-1143.
5. Ahmedat, A.; Warnken, M.; Seemann, W.; Mohr, K.; Kostenis, E.; Juergens, U.; Racké, K., Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system. Br. J. Pharmacol. 2013, 168, 471-487.
6. Wynn, T.A., Cellular and molecular mechanisms of fibrosis. J. Pathol. 2008, 214, 199-210.
7. Bullock, G.; Steyaert, I.; Bilbe, G.; Carey, R.M.; Kips, J.; de Paepe, B.; Pauwels, R.; Praet, M.; Siragy, H.M.; de Gasparo, M., Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem. Cell. Biol. 2001, 115, 117-124.
8. Cassis, L.; Shenoy, U.; Lipke, D.; Baughn, J.; Fettinger, M.; Gillespie, M., Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 1997, 54, 27-31.
9. Specks, U.; Martin, W.J., 2nd; Rohrbach, M.S., Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am. Rev. Respir. Dis. 1990, 141, 117-123.
10. Filippatos, G.; Tilak, M.; Pinillos, H.; Uhal, B.D., Regulation of apoptosis by angiotensin II in the heart and lungs. Int. J. Mol. Med. 2001, 7, 273-280.
11. Marshall, R.P.; McAnulty, R.J.; Laurent, G.J., Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care. Med. 2000, 161, 1999-2004.
12. Rassler, B.; Marx, G.; Reissig, C.; Rohling, M.A.; Tannapfel, A.; Wenger, R.H.; Zimmer, H.G., Time course of hypoxia-induced lung injury in rats. Respir. Physiol. Neurobiol. 2007, 159, 45-54.
13. Kalayarasan, S.; Sriram, N.; Sudhandiran, G., Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-κB, TNF-α and IL-1β. Life Sci. 2008, 82, 1142-1153.
14. Madonna, G.; Ullman, C.D.; Gentilcore, G.; Palmieri, G.; Ascierto, P.A., NF-κB as potential target in the treatment of melanoma. J. Transl. Med. 2012, 10, 53.
15. Ruiz-Ortega, M.; Rupérez, M.; Esteban, V.; Rodríguez-Vita, J.; Sánchez-López, E.; Carvajal, G.; Egido, J., Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 2006, 21, 16-20.
16. Pastor, M.D.; Nogal, A.; Molina-Pinelo, S.; Meléndez, R.; Romero-Romero, B.; Mediano, M.D.; López-Campos, J.L.; García-Carbonero, R.; Sanchez-Gastaldo, A.; Carnero, A., et al., Identification of oxidative stress related proteins as biomarkers for lung cancer and chronic obstructive pulmonary disease in bronchoalveolar lavage. Int. J. Mol. Sci. 2013, 14, 3440-3455.
17. Mancini, G.B.; Etminan, M.; Zhang, B.; Levesque, L.E.; FitzGerald, J.M. Brophy, J.M., Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J. Am. Coll. Cardiol. 2006, 47, 2554-2560.
18. Waseda, Y.; Yasui, M.; Nishizawa, Y.; Inuzuka, K.; Takato, H.; Ichikawa, Y.; Tagami, A.; Fujimura, M.; Nakao, S., Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice. Respir. Res. 2008, 9, 43.
19. Ruiz-Ortega, M.; Ruperez, M.; Esteban, V.; Egido, J., Molecular mechanisms of angiotensin II-induced vascular injury. Curr. Hypertens. Rep. 2003, 5, 73-79.
20. Edwards, M.R.; Bartlett, N.W.; Clarke, D.; Birrell, M.; Belvisi, M.; Johnston, S.L., Targeting the NF-κB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 2009, 121, 1-13.
21. Tamada, S.; Asai, T.; Kuwabara, N.; Iwai, T.; Uchida, J.; Teramoto, K.; Kaneda, N.; Yukimura, T.; Komiya, T.; Nakatani, T.; Miura, K., Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J. Pharmacol. Sci. 2006, 100, 17-21.
22. Muller, D.N.; Dechend, R.; Mervaala, E.M.; Park, J.K.; Schmidt, F.; Fiebeler, A.; Theuer, J.; Breu, V.; Ganten, D.; Haller, H., et al., NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000, 35, 193-201.
23. Kirk, J.M.; Heard, B.E.; Kerr, I.; Turner-Warwick, M.; Laurent, G.J., Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. Coll. Relat. Res. 1984, 4, 169-182.
24. Park, S.J.; Lee, K.S.; Lee, S.J.; Kim, S.R.; Park, S.Y.; Jeon, M.S.; Lee, H.B.; Lee, Y.C., L-2-Oxothiazolidine-4-Carboxylic acid or α-Lipoic acid attenuates airway remodeling: Involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF). Int. J. Mol. Sci. 2012, 13, 7915-7937.
25. Re, R.N., Implications of intracrine hormone action for physiology and medicine. Am. J. Physiol. Heart. Circ. Physiol. 2003, 284, H751-H757.
26. Krick, S.; Hänze, J.; Eul, B.; Savai, R.; Seay, U.; Grimminger, F.; Lohmeyer, J.; Klepetko, W.; Seeger, W.; Rose, F., Hypoxia-driven proliferation of human pulmonary artery fibroblasts: Cross-talk between HIF-1α and an autocrine angiotensin system. FASEB J. 2005, 19, 857-859.
27. Pendergrass, K.D.; Gwathmey, T.M.; Michalek, R.D.; Grayson, J.M.; Chappell, M.C., The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem. Biophys. Res. Commun. 2009, 384, 149-154.
28. Brasier, A.R.; Jamaluddin, M.; Han, Y.; Patterson, C.; Runge, M.S., Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-κB) transcription factor. Mol. Cell. Biochem. 2000, 212, 155-169.
29. Ihara, M.; Urata, H.; Kinoshita, A.; Suzumiya, J.; Sasaguri, M.; Kikuchi, M.; Ideishi, M.; Arakawa, K., Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999, 33, 1399-1405.
30. Orito, K.; Suzuki, Y.; Matsuda, H.; Shirai, M.; Akahori, F., Chymase is activated in the pulmonary inflammation and fibrosis induced by paraquat in hamsters. Tohoku J. Exp. Med. 2004, 203, 287-294.
31. Lang, Y.D.; Chang, S.F.; Wang, L.F.; Chen, C.M., Chymase mediates paraquat-induced collagen production in human lung fibroblasts. Toxicol. Lett. 2010, 193, 19-25.
32. Li, X.; Meng, Y.; Wu, P.; Zhang, Z.; Yang, X., Angiotensin II and Aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat. Regul. Pept. 2007, 138, 15-25.
33. Sármán, B.; Skoumal, R.; Leskinen, H.; Rysä, J.; Ilves, M.; Soini, Y.; Tuukkanen, J.; Pikkarainen, S.; Lakó-Futó, Z.; Sármán, B., et al., Nuclear factor-kappaB signaling contributes to severe, but not moderate, angiotensin II-induced left ventricular remodeling. J. Hypertens. 2007, 25, 1927-1939.
34. Gómez-Garre, D.; Largo, R.; Tejera, N.; Fortes, J.; Manzarbeitia, F., Egido, J., Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 2001, 37, 1171-1178.
35. Wolf, G.; Wenzel, U.; Burns, K.D.; Harris, R.C.; Stahl, R.A.; Thaiss, F., Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int. 2002, 61, 1986-1995.
36. Ruiz-Ortega, M.; Lorenzo, O.; Rupérez, M.; König, S.; Wittig, B.; Egido, J., Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ. Res. 2000, 86, 1266-1272.
37. Cairns, J.A.; Walls, A.F., Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 1997, 99, 1313-1321.
38. Zhou, T.B.; Qin, Y.H.; Li, Z.Y.; Xu, H.L.; Zhao, Y.J.; Lei, F.Y., All-trans retinoic acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats. Int. J. Mol. Sci. 2012, 13, 2769-2782.
39. Mifune, M.; Sasamura, H.; Shimizu-Hirota, R.; Miyazaki, H.; Saruta, T., Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells. Hypertension 2000, 36, 845-850.
40. Uhal, B.D.; Li, X.; Piasecki, C.C.; Molina-Molina, M., Angiotensin signalling in pulmonary fibrosis. Int. J. Biochem. Cell Biol. 2012, 44, 465-468.
41. Tang, J.M.; Wang, J.N.; Zhang, L.; Zheng, F.; Yang, J.Y.; Kong, X.; Guo, L.Y.; Chen, L.; Huang, Y.Z.; Wan, Y., et al., VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc. Res. 2011, 91, 402-411.
42. Tang, J.; Wang, J.; Kong, X.; Yang, J.; Guo, L.; Zheng, F.; Zhang, L.; Huang, Y.; Wan, Y., Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway. Exp. Cell. Res. 2009, 315, 3521-3531.
43. Lang, Y.D.; Hung, C.L.; Wu, T.Y.; Wang, L.F.; Chen, C.M., The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts. Free Radic. Biol. Med. 2010, 49, 88-95.